Market news

ASP Isotopes (NASDAQ:ASPI) expects several of its business units to enter commercial production or expand output over the next six months, with Chief Executive Officer Paul Mann highlighting progress in helium, liquefied natural gas, stable isotopes and radiopharmaceuticals during a conference prese

Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has started the commissioning phase of the Phase 1 Liquid Helium plant post engineering optimization The production is expected to be among the first new liquid helium supply to enter the market at a time of acute global shortage The Company remains on track to deliver liquid helium to customers during September and ramp production to nameplate capacity during 2H Following the successful start-up of Phase 1, the Comp

Tipranks Press Release.

DALLAS, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“we,” "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, is evaluating metal conversion opportunities in Namibia. As part of this evaluation, a public environmental and social impact assessment and consultation process has commenc

ASP Isotopes (NASDAQ:ASPI) outlined plans to expand its isotope production, radiopharmacy and helium businesses during Canaccord Genuity’s 46th Annual Growth Conference, with commercial deliveries of several stable isotopes targeted for the second half of 2026. Chief Commercial Officer Viktor Petko

Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has entered into an additional take-or-pay contract to supply liquified natural gas (LNG) to a domestic food processor, establishing a multi-year contracted cash flow supporting Phase 1 commercial operations, which remain targeted for completion in the third quarter of 2026 The LNG sale and purchase agreement, which is a five-year take-or-pay contract, is priced at greater than $16 /GJ (0.9478 MMBtu) of LNG, at curre

DALLAS, Aug. 05, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that it will host investor meetings at Citi's 2026 Natural Resources Conference on Thursday, August 13, 2026, in Las Vegas, Nevada. The latest investor presentation can be accessed under the Investors tab on the ASP Isotopes

DALLAS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes”, “ASPI” or the “Company”), an advanced materials comp...

DALLAS, July 30, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Viktor Petkov, Chief Commercial Officer, will deliver a company presentation on Wednesday, August 12, 2026, at 8:00 a.m. ET. A live audio webcast of the presentation will be available in the Investors section of the Comp

DALLAS, July 28, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that it will hold a Capital Markets Day in London on Tuesday, September 8, 2026, beginning at 10:00 a.m. ET (3:00 p.m. BST). During the event, leadership will provide a comprehensive update on the Company’s strategic directio

ASP Isotopes (NASDAQ:ASPI) executives outlined plans to create a publicly listed helium and liquefied natural gas platform through Noble Africa, emphasizing Renergen’s South African helium resource, expected near-term production milestones and the proposed merger with ENDRA Life Sciences. Paul Mann

Research Agreement Advances QLE's Effort to Develop Scalable Domestic Uranium Conversion Technology, a Critical U.S. Nuclear Fuel Supply Chain NeedDALLAS, July 21, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“we,” "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has signed a research agre

In July 2026, ASP Isotopes Inc. filed a shelf registration to offer 23,160,682 shares of common stock, with an aggregate value of US$106.08 million. We will now examine how ASP Isotopes’ broader investment narrative is shaping up.

ASP Isotopes (ASPI) has filed a shelf registration for up to US$106.1 million of common stock, covering 23,160,682 shares.

Detailed price information for Asp Isotopes Inc (ASPI-Q) from The Globe and Mail including charting and trades.

DALLAS & ANN ARBOR, Mich., July 17, 2026--ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or "ASPI"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, and ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or "NDRA"), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today announced that RedChip Companies will host an investor webinar

Exchange reduces QLE’s outstanding convertible notes by approximately 50% as QLE continues to pursue a public listing as a separate companyDALLAS, July 15, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASPI", the "Company" or “we”) today announced that ASPI and Quantum Leap Energy LLC ("QLE"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, have entered into separat